Quantitative Evaluation of Computed High b Value Diffusion-Weighted Magnetic Resonance Imaging of the Prostate

ObjectivesComputed diffusion-weighted magnetic resonance imaging (cDWI) refers to the synthesizing of arbitrary b value diffusion-weighted images (DWI) from a set of measured b value images by voxelwise fitting. The objectives of this study were to quantitatively analyze the noise and the contrast-to-noise ratio (CNR) in cDWI as a function of b value by numerical simulations and by measurements in patients with prostate cancer and to compare cDWI to directly measured DWI at a b value of 1400 s/mm2. Materials and MethodsNumerical simulations were performed to assess image noise and CNR in both cDWI and regular DWI. Forty-two patients with prostate cancer (age, 51–73 years; prostate specific antigen level, 0.5–30 ng/mL; and biopsy Gleason score, 6–9) received 2 DWI examinations at 3.0 T (one with b values of 100, 500, and 1400 s/mm2 and another with b values of 0, 100, 400, and 800 s/mm2) to create cDWI images at arbitrary b values, both with and without incorporating a b value of 0 s/mm2 in their calculation. Regions of interest were drawn to compare the scan time adjusted CNR (CNReff) between cDWI and directly measured DWI at b = 1400 s/mm2 on tumor-suspicious lesions and normal-appearing regions. ResultsIn the numerical simulations, noise depended strongly on the b value, the diffusion coefficient, and the signal intensity at a b value of 0 s/mm2 in cDWI but not in regular DWI. The CNR between simulated tumor and normal regions showed a continuous increase with increasing b value. Both these findings were also observed in tumor-suspicious and normal-appearing regions in in vivo data. In vivo prostate DWI at a b value of 1400 s/mm2 showed a similar CNReff between the tumor-suspicious regions and the normal-appearing tissue in cDWI as in the directly measured DWI (P = 0.395). ConclusionsThe CNReff between tumor-suspicious and normal-appearing prostate tissue in DWI images at a b value of 1400 s/mm2 is comparable in cDWI and directly measured DWI. Computed DWI at even higher b values, calculated from measured images with b values between 0 and 800 s/mm2, yields higher CNReff than measured DWI, which may be of clinical aid in the management of prostate cancer.

[1]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[2]  T. A. Carpenter,et al.  Optimised diffusion-weighting for measurement of apparent diffusion coefficient (ADC) in human brain. , 1997, Magnetic resonance imaging.

[3]  Peter Gibbs,et al.  Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.

[4]  D. Norris The effects of microscopic tissue parameters on the diffusion weighted magnetic resonance imaging experiment , 2001, NMR in biomedicine.

[5]  B. Issa,et al.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[6]  L. Hall,et al.  Optimization of diffusion measurements using Cramer‐Rao lower bound theory and its application to articular cartilage , 2003, Magnetic resonance in medicine.

[7]  C. Boesch,et al.  Diffusion‐weighted imaging of the parotid gland: Influence of the choice of b‐values on the apparent diffusion coefficient value , 2004, Journal of magnetic resonance imaging : JMRI.

[8]  Stephan E Maier,et al.  Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. , 2004, Neoplasia.

[9]  Frederik De Keyzer,et al.  Extracranial applications of diffusion-weighted magnetic resonance imaging , 2007, European Radiology.

[10]  L. Turnbull,et al.  Diffusion‐weighted imaging of normal and malignant prostate tissue at 3.0T , 2006, Journal of magnetic resonance imaging : JMRI.

[11]  Dow-Mu Koh,et al.  Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. , 2007, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[12]  Hiroshi Iino,et al.  High-b value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results. , 2007, AJR. American journal of roentgenology.

[13]  D. Collins,et al.  Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.

[14]  K. Sugimura,et al.  High b-value diffusion-weighted imaging in normal and malignant peripheral zone tissue of the prostate: effect of signal-to-noise ratio. , 2008, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[15]  Katsuyoshi Ito,et al.  Apparent diffusion coefficient values in peripheral and transition zones of the prostate: Comparison between normal and malignant prostatic tissues and correlation with histologic grade , 2008, Journal of magnetic resonance imaging : JMRI.

[16]  A. Evans,et al.  Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[17]  Gary P Liney,et al.  Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 Tesla , 2009, Investigative radiology.

[18]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[19]  C. Kim,et al.  Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. , 2010, AJR. American journal of roentgenology.

[20]  C. Kim,et al.  High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. , 2010, AJR. American journal of roentgenology.

[21]  Y. Yamashita,et al.  Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation , 2010, European Radiology.

[22]  Peter R Luijten,et al.  Quantitative diffusion weighted imaging for differentiation of benign and malignant breast lesions: The influence of the choice of b‐values , 2010, Journal of magnetic resonance imaging : JMRI.

[23]  Thomas Hambrock,et al.  Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.

[24]  J. Babb,et al.  Prostate cancer: Utility of fusion of T2‐weighted and high b‐value diffusion‐weighted images for peripheral zone tumor detection and localization , 2011, Journal of magnetic resonance imaging : JMRI.

[25]  T. Metens,et al.  What is the optimal b value in diffusion-weighted MR imaging to depict prostate cancer at 3T? , 2012, European Radiology.

[26]  Ralph Strecker,et al.  Areas Suspicious for Prostate Cancer : MR – guided Biopsy in Patients with at Least One Transrectal US-guided Biopsy with a Negative Finding — Multiparametric MR Imaging for Detection and Biopsy Planning 1 , 2011 .

[27]  Thomas Hambrock,et al.  Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.

[28]  S. Verma,et al.  Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. , 2011, AJR. American journal of roentgenology.

[29]  Ralph Strecker,et al.  Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding--multiparametric MR imaging for detection and biopsy planning. , 2011, Radiology.

[30]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[31]  D. Collins,et al.  Computed diffusion-weighted MR imaging may improve tumor detection. , 2011, Radiology.

[32]  T. Scheenen,et al.  Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T. , 2012, Radiology.

[33]  Thomas Hambrock,et al.  Initial Experience With Identifying High-Grade Prostate Cancer Using Diffusion-Weighted MR Imaging (DWI) in Patients With a Gleason Score ⩽3 + 3 = 6 Upon Schematic TRUS-Guided Biopsy: A Radical Prostatectomy Correlated Series , 2012, Investigative radiology.

[34]  Takeshi Yoshikawa,et al.  Clinical utility of apparent diffusion coefficient values obtained using high b‐value when diagnosing prostate cancer using 3 tesla MRI: Comparison between ultra‐high b‐value (2000 s/mm2) and standard high b‐value (1000 s/mm2) , 2012, Journal of magnetic resonance imaging : JMRI.

[35]  L. R. Jensen,et al.  Peripheral Zone Prostate Cancer Localization by Multiparametric Magnetic Resonance at 3 T: Unbiased Cancer Identification by Matching to Histopathology , 2012, Investigative radiology.

[36]  Thomas Hambrock,et al.  Evaluation of Diffusion-Weighted MR Imaging at Inclusion in an Active Surveillance Protocol for Low-Risk Prostate Cancer , 2013, Investigative radiology.